BlackRock Inc (BLK)vsApplied DNA Sciences, Inc. (BNBX)
BLK
BlackRock Inc
$1,065.80
-1.28%
FINANCIAL SERVICES · Cap: $175.42B
BNBX
Applied DNA Sciences, Inc.
$0.16
+5.47%
FINANCIAL SERVICES · Cap: $2.72M
Smart Verdict
WallStSmart Research — data-driven comparison
BlackRock Inc generates 1304013% more annual revenue ($27.30B vs $2.09M). BLK leads profitability with a 24.1% profit margin vs 0.0%. BLK appears more attractively valued with a PEG of 0.89. BLK earns a higher WallStSmart Score of 78/100 (B+).
BLK
Strong Buy78
out of 100
Grade: B+
BNBX
Hold48
out of 100
Grade: D+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 35.1%
Revenue surging 30.6% year-over-year
Large-cap with strong market position
Keeps 24 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 34.3% year-over-year
Areas to Watch
Moderate valuation
Weak financial health signals
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BLK
The strongest argument for BLK centers on Operating Margin, Revenue Growth, Market Cap. Profitability is solid with margins at 24.1% and operating margin at 35.1%. Revenue growth of 30.6% demonstrates continued momentum.
Bull Case : BNBX
The strongest argument for BNBX centers on Price/Book, Revenue Growth. Revenue growth of 34.3% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bear Case : BLK
The primary concerns for BLK are P/E Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : BNBX
The primary concerns for BNBX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
BLK profiles as a growth stock while BNBX is a hypergrowth play — different risk/reward profiles.
BLK carries more volatility with a beta of 1.43 — expect wider price swings.
BNBX is growing revenue faster at 34.3% — sustainability is the question.
BLK generates stronger free cash flow (32M), providing more financial flexibility.
Bottom Line
BLK scores higher overall (78/100 vs 48/100), backed by strong 24.1% margins and 30.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
BlackRock Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock, Inc. is an American multinational investment management corporation based in New York City.
Applied DNA Sciences, Inc.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?